OTC Markets OTCQB - Delayed Quote USD
Satellos Bioscience Inc. (MSCLF)
0.5020
0.0000
(0.00%)
At close: April 23 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Cash Flow
-24,975
-24,975
-11,585
-5,783
-5,033.7110
Investing Cash Flow
6,338
6,338
-17,538
-3
1,738.1760
Financing Cash Flow
53,485
53,485
50,429
2,775
7,450.7120
End Cash Position
57,659
57,659
22,067
1,924
4,871.2630
Capital Expenditure
-6
-6
-18
-3
-7.2460
Issuance of Capital Stock
42,802
42,802
32,463
2,775
7,078.6760
Issuance of Debt
--
--
2,244
--
186.5730
Repayment of Debt
--
--
-2,622
--
--
Free Cash Flow
-24,981
-24,981
-11,603
-5,786
-5,040.9570
12/31/2021 - 8/3/2012
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
BETRF BetterLife Pharma Inc.
0.0680
0.00%
EPRX Eupraxia Pharmaceuticals Inc.
3.8400
-0.26%
NGENF NervGen Pharma Corp.
2.1300
-0.93%
MDNAF Medicenna Therapeutics Corp.
0.7590
-0.78%
ARTH Arch Therapeutics, Inc.
0.1608
0.00%
ACXP Acurx Pharmaceuticals, Inc.
0.3870
+2.73%
NGEN.V NervGen Pharma Corp.
2.9500
0.00%
PYPD PolyPid Ltd.
2.7500
+0.36%
EPRX.TO Eupraxia Pharmaceuticals Inc.
5.28
0.00%
ACOG Alpha Cognition Inc. Common Stock
4.9200
+7.89%